News

Researchers used digital polymerase chain reaction assays to measure BRAF V600E or BRAF V600K circulating tumor DNA in ...
Consider the many challenges of medical school: The volume of knowledge you’re expected to master, the fast pace, the competition, long hours in clinical training, the pressure to succeed, the ...
Dr Pavan Bhargava gives insights on earlier diagnosis, ocrelizumab safety in pregnancy, and promising anti-aging effects of diet in RRMS.
The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently diagnosed with Parkinson’s Disease ...
Botox isn’t just for wrinkles. It’s also helping patients with retrograde cricopharyngeal dysfunction finally burp and breathe easier.
In 2006, Casarett published a case report in the AMA Journal of Ethics describing a patient with lung cancer who experienced a series of hospitalizations, including for febrile neutropenia, a common ...
Aaron Holley, MD, writes that it takes a 'physiologic village' to create activity intolerance after pulmonary embolism, and argues for more use of cardiopulmonary exercise testing to evaluate it.
Dr Nicholas Silvestri reports that the 2025 AAN meeting highlighted significant advances in myasthenia gravis, including improved diagnostics and emerging therapies.
Research on the gut microbiome has focused mainly on bacteria, but bacteriophages and fungi play critical roles as well, with significant influences on health and disease.
Cervical artery dissection–related hospitalizations rose more than fourfold in 15 years in the United States, new research shows.
Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain following bariatric surgery, a Swiss real-world study reveals.
Severe postpartum haemorrhage in women with grade 3 placenta accreta spectrum demonstrates significantly better outcomes in Italy than in the United Kingdom and France.